- Home
- JEQ vs ADAG Comparison
JEQ vs ADAG Comparison
Compare JEQ & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEQ
- ADAG
- Stock Information
- Founded
- JEQ 1990
- ADAG 2011
- Country
- JEQ United States
- ADAG China
- Employees
- JEQ N/A
- ADAG N/A
- Industry
- JEQ Air Freight/Delivery Services
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- JEQ Consumer Discretionary
- ADAG Health Care
- Exchange
- JEQ Nasdaq
- ADAG Nasdaq
- Market Cap
- JEQ 88.1M
- ADAG 76.3M
- IPO Year
- JEQ N/A
- ADAG 2021
- Fundamental
- Price
- JEQ $7.13
- ADAG $1.90
- Analyst Decision
- JEQ
- ADAG Strong Buy
- Analyst Count
- JEQ 0
- ADAG 1
- Target Price
- JEQ N/A
- ADAG $8.00
- AVG Volume (30 Days)
- JEQ 32.0K
- ADAG 75.4K
- Earning Date
- JEQ 01-01-0001
- ADAG 07-24-2025
- Dividend Yield
- JEQ 7.05%
- ADAG N/A
- EPS Growth
- JEQ N/A
- ADAG N/A
- EPS
- JEQ N/A
- ADAG N/A
- Revenue
- JEQ N/A
- ADAG $103,204.00
- Revenue This Year
- JEQ N/A
- ADAG $6,488.89
- Revenue Next Year
- JEQ N/A
- ADAG $57.50
- P/E Ratio
- JEQ N/A
- ADAG N/A
- Revenue Growth
- JEQ N/A
- ADAG N/A
- 52 Week Low
- JEQ $4.99
- ADAG $1.33
- 52 Week High
- JEQ $6.39
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- JEQ 52.12
- ADAG 52.47
- Support Level
- JEQ $7.08
- ADAG $1.73
- Resistance Level
- JEQ $7.87
- ADAG $2.02
- Average True Range (ATR)
- JEQ 0.12
- ADAG 0.15
- MACD
- JEQ -0.03
- ADAG -0.01
- Stochastic Oscillator
- JEQ 5.70
- ADAG 42.50
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.